Lubiprostone: Preliminary Phase III data

Top-line data from 875 patients in the 2 identically-designed, double-blind, placebo-controlled, U.S. and Canadian Phase III OBD0631 and OBD0632 trials showed that lubiprostone met the primary endpoin...